Elinogrel
Elinogrel (pronounced: eh-lih-NOH-grel) is a type of pharmaceutical drug that belongs to the class of P2Y12 inhibitors. It is primarily used in the prevention of blood clots in patients with certain types of cardiovascular disease.
Etymology
The term "Elinogrel" is derived from the Greek words "elinon" meaning "olive" and "grel" meaning "to break". This is in reference to the drug's ability to prevent the formation of blood clots, similar to how an olive is broken down in the body.
Pharmacology
Elinogrel works by inhibiting the P2Y12 receptor, a protein found on the surface of platelet cells. By blocking this receptor, Elinogrel prevents platelets from sticking together and forming a clot. This can help to prevent heart attacks and strokes in patients with cardiovascular disease.
Related Terms
- P2Y12 inhibitor: A class of drugs that prevent blood clots by blocking the P2Y12 receptor on platelets.
- Platelet: A type of blood cell that plays a key role in blood clotting.
- Cardiovascular disease: A class of diseases that involve the heart or blood vessels.
- Blood clot: A clump of blood that has changed from a liquid to a gel-like or semisolid state.
- Heart attack: A serious medical condition in which the supply of blood to the heart is suddenly blocked.
- Stroke: A serious medical condition in which the supply of blood to the brain is interrupted.
External links
- Medical encyclopedia article on Elinogrel
- Wikipedia's article - Elinogrel
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski